Common questions about Levedad (FAQ)
Q: Does Levedad change how I react to alcohol?
Regulatory documents state that using alcohol is a factor that can increase the risk of serious gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs (NSAIDs) like Levedad. These serious effects include bleeding and ulceration in the stomach or intestines. This risk profile is included in the regulatory warnings.
Q: Are there any common foods that interact with Levedad?
Official documents state that taking Levedad with food does not significantly change the total amount of the drug that your body absorbs. However, eating food may delay the time it takes for the medicine to begin working. This information is typically found in the clinical pharmacology sections of the product information.
Q: Is Levedad safe for people with kidney problems?
Official labeling advises that long-term use of NSAIDs can potentially result in kidney injury. Official labeling indicates that caution is necessary for use in individuals with pre-existing impaired kidney function. The medicine is contraindicated (should not be used) in people with severe kidney impairment.
Q: Can I take Levedad if I have high blood pressure?
Official documents note that Levedad can lead to new onset of high blood pressure (hypertension) or worsen existing high blood pressure. Official documents describe the need for close blood pressure monitoring during treatment initiation and throughout therapy for individuals with high blood pressure.
Q: Is Levedad considered a scheduled drug or a controlled substance?
Levedad, which contains diclofenac, is classified as a nonsteroidal anti-inflammatory drug (NSAID). According to U.S. federal regulation, it is not designated as a controlled substance and is not related to narcotic or opioid drug classes.
Q: Does Levedad need to be stopped gradually?
Official instructions indicate that changes to the dose or stopping the medicine should not occur without consulting a healthcare provider. This ensures any necessary adjustments or cessation plans are medically reviewed.
Q: Are there any known interactions between Levedad and common supplements like vitamins or herbs?
Authoritative guidance often notes that there is insufficient information available to determine the safety of taking certain complementary medicines, herbal remedies, and general supplements with Levedad. Patient information suggests discussing all supplements being used with a healthcare provider.
Q: What should a person do if they notice a new or worsening symptom while on Levedad?
Patient information describes specific symptoms that warrant immediate professional medical attention, which may involve discontinuing the medicine. These symptoms could include severe chest pain, sudden weakness, or signs of bleeding such as vomiting blood or having black, tarry stools.
Q: How quickly does Levedad start to affect the body?
The onset of action, which is when the medicine begins to work, is generally described in official data. For oral non-gel forms, this typically begins within 30 minutes. For topical gel applications, the onset of action is generally observed within 4 hours.
Q: Is it normal to feel tired during the first week of taking Levedad?
Official safety information includes sleepiness or unusual drowsiness as a possible adverse effect. This indicates that sleepiness or unusual drowsiness is a possibility that has been reported.
Q: Does Levedad have any warnings about driving or operating machinery?
Because of the potential for side effects such as dizziness and sleepiness, official information advises people to be cautious when driving or operating machinery until they understand how the drug affects their alertness.
Q: How long does the effect of one dose of Levedad last?
Pharmacokinetic data suggests that the duration of pain relief following a single dose has been documented to last up to eight hours, depending on the specific formulation being used.
Q: Does Levedad cause weight changes?
Rapid or unexplained weight gain along with swelling is specifically mentioned in patient information as a symptom of fluid retention. This symptom is highlighted as one that should be discussed immediately with a healthcare provider.
Q: Are there different forms or strengths of Levedad available?
Yes, Levedad is available in multiple formulations and strengths. This includes oral forms like delayed-release tablets (e.g., 25 mg, 50 mg, 75 mg) and extended-release tablets (e.g., 100 mg), as well as topical, rectal, and injectable forms.
Q: Is Levedad habit-forming or does it cause dependence?
Levedad is classified as a nonsteroidal anti-inflammatory drug (NSAID) and is not a controlled substance. This classification indicates it does not carry the same risk profile for dependence as narcotic or opioid drug classes.
Q: Is it okay to take over-the-counter pain relievers while using Levedad?
Official guidance indicates that Levedad may be safely combined with other pain relievers such as paracetamol. Regulatory guidance indicates that it should not be taken with other NSAIDs, such as ibuprofen or naproxen, because combining these medicines significantly increases the risk of side effects.
Q: Does Levedad affect sleep patterns?
Official safety information lists sleepiness or unusual drowsiness as a possible adverse effect. This potential effect should be considered when assessing its use, particularly around activities that require alertness.
Q: What is the full list of ingredients in Levedad, besides the main drug?
Official labeling provides a complete list of all ingredients, including the inactive components (excipients), for each specific product formulation. These inactive ingredients may include materials like coloring agents, stabilizers, and coatings.
Q: Is Levedad generally prescribed as a long-term or short-term treatment?
The official prescribing principle is to use the lowest effective dose for the shortest duration possible. This principle is consistent with the regulatory warning that the risk of serious cardiovascular events is known to increase with the duration of use.
Q: Are there specific tests needed before starting Levedad?
Official guidance requires a healthcare provider to evaluate the patient for specific pre-existing conditions before starting Levedad. This evaluation involves reviewing factors such as a history of gastrointestinal bleeding or ulceration, and pre-existing heart, liver, or kidney problems.
Q: What is the risk of a severe allergic reaction to Levedad?
The official safety profile includes warnings about the risk of serious and potentially fatal skin reactions, such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Q: Does being pregnant or breastfeeding affect who can use Levedad?
Levedad is contraindicated (should not be used) during the third trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus. Use during other trimesters, or while breastfeeding, is a matter for professional medical evaluation.
Q: Is there a generic version of Levedad available?
Yes, the active ingredient in Levedad is diclofenac, which is widely available as a generic medicine. Multiple formulations of generic diclofenac have been approved by regulatory bodies.
Q: What is the difference between the brand name and generic versions of Levedad?
Generic and brand-name versions of Levedad contain the exact same active ingredient and are required to meet bioequivalence standards set by regulatory authorities. However, the inactive ingredients, such as coloring agents or coatings, may differ.
Q: Are there any specific lifestyle changes that are recommended while using Levedad?
Yes, patient information for the topical formulation advises avoiding exposure of the treated area to natural or artificial sunlight. Patient information also notes that contact with the eyes or mucous membranes should be avoided.
Q: What age group is Levedad generally prescribed for?
Levedad is primarily used for adults. However, official regulatory documents indicate that some specific formulations and indications are also approved for use in pediatric patients aged 12 years and older.
Q: Why does the packaging for Levedad have a specific warning?
Official labeling contains a Boxed Warning that highlights the increased risk of serious adverse events associated with all NSAIDs. Specifically, this warning addresses the risks of cardiovascular thrombotic events (like heart attack or stroke) and gastrointestinal bleeding, ulceration, and perforation.
Q: Does Levedad interact with caffeine?
While no direct interaction with caffeine alone is usually cited, an interaction has been noted in combination products containing caffeine along with other specific analgesics. It is noted that people should inform their healthcare provider of all substances consumed.
Q: Are there any limitations on who can participate in studies about Levedad?
Yes, clinical studies conducted on Levedad have specific inclusion and exclusion criteria. These criteria are based on factors such as a participant's age, pre-existing conditions, and the need for a washout period from other pain medications.
